0001013762-23-002552.txt : 20231006 0001013762-23-002552.hdr.sgml : 20231006 20231006163246 ACCESSION NUMBER: 0001013762-23-002552 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230801 FILED AS OF DATE: 20231006 DATE AS OF CHANGE: 20231006 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Abildgaard Ole CENTRAL INDEX KEY: 0001994976 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38758 FILM NUMBER: 231314586 MAIL ADDRESS: STREET 1: VEDBAEK STRANDVEJ 506 CITY: VEDBAEK STATE: G7 ZIP: 2950 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RENOVARO BIOSCIENCES INC. CENTRAL INDEX KEY: 0001527728 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452259340 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: CENTURY CITY MEDICAL PLAZA STREET 2: 2080 CENTURY CITY EAST CITY: SUITE 906 LOS ANGELES STATE: CA ZIP: 90067 BUSINESS PHONE: 45 39179840 MAIL ADDRESS: STREET 1: CENTURY CITY MEDICAL PLAZA STREET 2: 2080 CENTURY CITY EAST CITY: SUITE 906 LOS ANGELES STATE: CA ZIP: 90067 FORMER COMPANY: FORMER CONFORMED NAME: Enochian Biosciences Inc. DATE OF NAME CHANGE: 20230804 FORMER COMPANY: FORMER CONFORMED NAME: Renovaro Biosciences Inc. DATE OF NAME CHANGE: 20230802 FORMER COMPANY: FORMER CONFORMED NAME: Enochian Biosciences Inc DATE OF NAME CHANGE: 20180306 3 1 ownership.xml X0206 3 2023-08-01 0 0001527728 RENOVARO BIOSCIENCES INC. RENB 0001994976 Abildgaard Ole VEDBAEK STRANDVEJ 506 VEDBAEK G7 2970 DENMARK 0 0 1 0 Common Stock 3462292 I By Paseco ApS Common Stock 5000 D Series A Convertible Preferred Stock 0 2023-08-01 Common Stock 3436190 I By Paseco ApS Warrants (right to buy) 1.14 2023-03-29 2028-03-29 Common Stock 125000 I By Paseco ApS Warrants (right to buy) 0.53 2023-06-26 2028-06-26 Common Stock 1415870 I By Paseco ApS Warrants (right to buy) 0.65 2023-08-01 2028-08-01 Common Stock 1718095 I By Paseco ApS The Series A Convertible Preferred Stock ("Preferred Stock") is convertible into Common Stock on a one-for-ten basis and has no expiration date Ole Abildgaard, as Chief Executive Officer and sole shareholder of Paseco ApS, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. /s/ Ole Abildgaard 2023-10-06